Compare YHC & VIVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | YHC | VIVS |
|---|---|---|
| Founded | 2021 | 2007 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Beverages (Production/Distribution) | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Consumer Staples | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.2M | 2.1M |
| IPO Year | 2023 | 2010 |
| Metric | YHC | VIVS |
|---|---|---|
| Price | $1.61 | $0.14 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 235.0K | ★ 772.9K |
| Earning Date | 11-17-2026 | 11-17-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 8.28 | N/A |
| Revenue | $1,120,622.00 | ★ $4,603,000.00 |
| Revenue This Year | $1,254.00 | $228,144.28 |
| Revenue Next Year | $21.74 | N/A |
| P/E Ratio | $0.27 | ★ N/A |
| Revenue Growth | ★ 86.42 | 8.82 |
| 52 Week Low | $1.21 | $0.14 |
| 52 Week High | $4,480.00 | $3.40 |
| Indicator | YHC | VIVS |
|---|---|---|
| Relative Strength Index (RSI) | 42.90 | 34.12 |
| Support Level | $1.41 | $0.14 |
| Resistance Level | $1.97 | $0.30 |
| Average True Range (ATR) | 0.44 | 0.02 |
| MACD | -0.02 | 0.00 |
| Stochastic Oscillator | 20.24 | 12.68 |
LQR House Inc intends to become the full-service digital marketing and brand development face of the alcoholic beverage space. It also intends to integrate the supply, sales, and marketing facets of the alcoholic beverage space into one easy-to-use platform and become the one-stop shop for everything related to alcohol. The company's primary business includes the development of premium limited-batch spirit brands, establishing an exclusive wine club, and marketing internal and external brands through an exclusive agreement with a United States-based e-commerce portal. It believes that the marketing and brand management services it provides to its wholly owned and third-party clients will increase brand recognition, and drive sales thereof through its e-commerce platform partner.
VivoSim Labs Inc is a pharmaceutical and biotechnology services company focused on testing drugs and drug candidates in three-dimensional human tissue models of the liver and intestine. The Company provides liver and intestinal toxicology insights using its new approach methodologies and models and offers liver toxicology predictive screening and research services, as well as services to predict and study the intestinal side effect profiles of therapeutic candidates at all stages of drug development. Its 3D human tissue platform includes expertise in 3D organoids, such as spheroids, and proprietary cell culture techniques.